MAY 12, 2025
Please join us for an exclusive sneak peek of the forthcoming documentary
Cracking the Code: Phil Sharp and the Biotech Revolution
Cracking the Code is a powerful reminder that breakthroughs and life-saving biotech treatments don’t happen by accident. They happen because of a unique ecosystem—one that supports bold ideas, invests in basic research, and encourages entrepreneurs to take risks. The market plays a critical role in this ecosystem, turning scientific discoveries into real-world solutions that improve lives and drive economic growth. Phil Sharp’s journey—from groundbreaking research to founding transformative companies like Biogen and Alnylam—shows how science, entrepreneurship, and the market can work together to solve humanity’s greatest challenges.
May 12, 2025
5:00pm – Film Screening and Discussion
7:00pm – Post-Screening Reception
The Times Center
242 W 41st St, New York, NY ​
​
Doors open at 4:30pm. Please arrive with ample time to find a seat.
Please join us for a post-screening conversation with Phil Sharp, Bill Haney, and Clint Gartin followed by a networking reception with food and drinks.
Phillip A. Sharp, PhD – Phillip A. Sharp, an Institute Professor emeritus at MIT, is a member of the Department of Biology and the Koch Institute for Integrative Cancer Research. His work studying the molecular biology of gene expression relevant to cancer and the mechanisms of RNA splicing earned Sharp the 1993 Nobel Prize in Physiology for Medicine. Sharp is past President of AAAS, serves on the boards of directors of the Broad Institute, Stand Up 2 Cancer, and the Gairdner Foundation. He is a co-founder of Biogen and of Alnylam Pharmaceuticals and serves on the Scientific Advisory Boards of F-Prime Capital, Alnylam Pharmaceuticals, Danahers, Dewpoint Therapeutics, and Skyhawk Therapeutics, He is also advisor to Longwood and Polaris Venture Funds.
Clint Gartin – Clint Gartin is a Senior Advisor at Morgan Stanley and was the Chairman of Investment Banking at Morgan Stanley for eight years. He was previously the head of Morgan Stanley’s Healthcare Investment Banking Group for seventeen years. He has also served as the Chief Operating Officer of Morgan Stanley’s Investment Banking Division and as the head of its Global Industries Group. Mr. Gartin has been involved in over $1.6 trillion of merger and acquisition transactions and has been involved in over 150 capital raising events. His clients include some of the largest companies in the world. Mr. Gartin received a degree in accounting from the University of Connecticut where he was a University Scholar and graduated summa cum laude. He joined Morgan Stanley in 1981 after receiving an MBA from Harvard Business School.
Bill Haney – Bill Haney is a filmmaker, inventor, and entrepreneur. His most recent film projects include Cracking the Code: Phil Sharp and the Biotech Revolution, and Jim Allison: Breakthrough. He has started more than a dozen companies and is currently the Co-founder and CEO of Dragonfly Therapeutics, a clinical stage biotech focused on novel NK-cell based immune engagers, and Co-founder & Chairman of Skyhawk Therapeutics, a clinical stage biotech focused on small molecule RNA splicing modifiers. Bill is a graduate of Harvard College and served as a Fellow of Harvard's Kennedy School.
CO-HOSTED BY
This event has ended.
ABOUT THE FILM
Cracking the Code, narrated by Mark Ruffalo, is an inspiring story of vision, perseverance, and the power of science to change the world. Phil Sharp’s journey from a Kentucky farm boy to Nobel laureate embodies the American Dream and the triumph of entrepreneurial spirit. His 1977 groundbreaking discovery of RNA splicing rewrote the rules of molecular biology and ignited a life-saving scientific revolution, laying the foundation for an industry that has become a cornerstone of global innovation and economic growth – and transformed the health of billions of patients worldwide.
